Post-Brexit MedTech: Your Guide from FDA to UKCA Marking

This episode breaks down the essential steps for medical device manufacturers with FDA clearance to successfully enter the post-Brexit UK market. We clarify why FDA approval isn't recognized by the MHRA and detail the two main pathways to achieving UKCA certification: leveraging the CE mark transition period and direct conformity assessment. Learn about critical deadlines, the role of the UK Responsible Person, and how to stay compliant. Key Questions: • Does my FDA 510(k) clearance fast-track UK market access? • What is the UKCA mark and how does it differ from a CE mark? • Can I still use my existing CE mark to sell devices in Great Britain? • What are the hard deadlines for transitioning from CE marking to the UKCA mark? • Do I need a UK-based representative to register my devices? • What is a UK Responsible Person (UKRP) and what are their duties? • How do the regulations for Great Britain differ from Northern Ireland? • What documentation is required for a UKCA technical file? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.